Charles Peloquin, Pharm.D.
Professor
Department:
Pharmacotherapy & Translational Research
Business Phone:
(352) 273-6266
Business Email:
peloquin@cop.ufl.edu
About Charles Peloquin
Prior to coming to the University of Florida, Dr. Peloquin completed a hospital pharmacy residency at Duke University Medical Center, where he also served on the clinical staff. He also completed a fellowship in Infectious Diseases and Pharmacokinetics at the Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, N.Y. For 20 years, Dr. Peloquin was the Director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) at National Jewish Medical and Research Center, Denver, CO. He now serves as Professor of Pharmacy and Medicine at UF, where the IDPL is now located. Dr. Peloquin and his lab are part of the UF Emerging Pathogens Institute. He also is a consultant to the FDA and CDC.
Honors & Awards
Member
2004-Current
·
International Society of Antimicrobial Pharmacology
Member
1991-Current
·
Society of Infectious Disease Pharmacists
Member
1990-Current
·
American Society of Microbiology
Member
1986-Current
·
American College of Clinical Pharmacy
Publications
2020
Antimicrobial Agents and Chemotherapy
2019
American Journal of Respiratory and Critical Care Medicine
2019
Antimicrobial Agents and Chemotherapy
2019
Antimicrobial Agents and Chemotherapy
2019
˜The œinternational journal of tuberculosis and lung disease (Online)
2019
Clinical Infectious Diseases
2019
Antimicrobial Agents and Chemotherapy
2019
American Journal of Respiratory and Critical Care Medicine
2019
Antimicrobial Agents and Chemotherapy
2019
Antimicrobial Agents and Chemotherapy
2019
Antimicrobial Agents and Chemotherapy
2019
Therapeutic Drug Monitoring
2019
Antimicrobial Agents and Chemotherapy
2019
Clinical Infectious Diseases
2019
Journal of Antimicrobial Chemotherapy
2019
American Journal of Respiratory and Critical Care Medicine
2019
American Journal of Respiratory and Critical Care Medicine
2019
International Journal of Antimicrobial Agents
2018
Antimicrobial agents and chemotherapy
2018
International Journal of Mycobacteriology
2018
Antimicrobial Agents and Chemotherapy
2018
Antimicrobial Agents and Chemotherapy
2018
Science Translational Medicine
2018
The Journal Of Antimicrobial Chemotherapy
2018
Antimicrobial agents and chemotherapy
2018
Microbiology insights
2018
Antimicrobial agents and chemotherapy
2017
Antimicrobial Agents and Chemotherapy
2017
Journal of Pharmaceutical Sciences
2017
Clinical Pharmacology & Therapeutics
2016
Journal of Antimicrobial Chemotherapy
2016
Journal of Antimicrobial Chemotherapy
2015
Journal of Veterinary Pharmacology and Therapeutics
2015
Clinical Pharmacology & Therapeutics
2014
Journal of Antimicrobial Chemotherapy
2014
Journal of Veterinary Pharmacology and Therapeutics
2013
American Journal of Respiratory and Critical Care Medicine
2012
Journal of Antimicrobial Chemotherapy
2012
Arthritis and Rheumatism
2012
The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium Avium Complex Disease Treatment
American Journal of Respiratory and Critical Care Medicine
2011
Current Pharmaceutical Design
2011
American Journal of Respiratory and Critical Care Medicine
2010
Journal of Antimicrobial Chemotherapy
2010
Annals of Pharmacotherapy
Grants
Nov 2019
ACTIVE
LegoChem Data Analysis – Task Order #1
LEGOCHEM BIOSCIENCES
·
Principal Investigator
May 2019
ACTIVE
Development of Gleevec for TB and TB/HIV
EMORY UNIV
·
Principal Investigator
Feb 2019
ACTIVE
Diagnostics and Pharmacotherapy for Severe Forms of TB
UNIV OF VIRGINIA
·
Principal Investigator
Sep 2018
ACTIVE
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD
·
Jul 2018
ACTIVE
An Exploratory Study of Anti-Tuberculosis Drug Penetration into Cerebrospinal Fluid
EMORY UNIV
·
Principal Investigator
Feb 2018
– Jan 2019
Diagnostics and Pharmacotherapy for Severe Forms of TB
UNIV OF VIRGINIA
·
Principal Investigator
Oct 2017
– Dec 2018
Screening and Treatment of Children and Adults Exposed at Home to Drug-Resistant Tuberculosis
HARVARD MEDICAL SCHOOL
·
Principal Investigator
Aug 2017
ACTIVE
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
BOSTON UNIV
·
Principal Investigator
Aug 2016
ACTIVE
Optimizing combination therapy for accelerate clinical cure of tuberculosis
NATL INST OF HLTH NIAID
·
Jul 2016
– May 2017
Pharmacokinetics of second-line anti-tuberculosis drugs among patients with multidrug-resistant tuberculosis
INTL SCIENCE AND TECHNOLOGY CENTER
·
Principal Investigator
Jun 2016
– Aug 2018
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD
·
Feb 2016
– Jan 2018
MD-INMD Diagnostics and Pharmacotherapy for Service Year 2
UNIV OF VIRGINIA
·
Principal Investigator
Feb 2016
– Jan 2018
A Clinical Pharmacology Study of a Novel Drug Regimen for Pre XDR and XDR Tuberculosis
EMORY UNIV
·
Principal Investigator
Sep 2015
– Mar 2017
task A73: Combination drug testing for new TB regimens
TEXAS A&M RES FOU
·
Principal Investigator
Aug 2014
– Dec 2018
Rifampin and Lopinavir Study
UNIV OF MIAMI
·
Principal Investigator
Mar 2014
– Jun 2018
Pharmacokinetics and Pharmacodynamics of Tuberculosis Dr
CRITICAL PATH INSTITUTE
·
Principal Investigator
Feb 2014
– Feb 2017
Advanced Neuroimaging Evaluation of the Central Nervous
BRIGHAM AND WOMENS HOSPITAL
·
Principal Investigator
Feb 2014
– Jul 2017
Immune Activation and Drug Absorption in HIV-Infected Pa
DREXEL UNIVERSITY
·
Principal Investigator
Aug 2013
– Jul 2018
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment
BOSTON UNIV
·
Principal Investigator
Jul 2013
– Jun 2016
Intracavitary Drug Levels in Patients with Drug Resistan
EMORY UNIV
·
Principal Investigator
Jun 2009
ACTIVE
Moxifloxain PK in Bile.
MULTIPLE SPONSORS
·
Principal Investigator
Education
Pharm.D.
1986
·
Philadelphia College of Pharmacy and Science
B.S.
1981
·
University of Connecticut
Contact Details
Phones:
- Business:
- (352) 273-6266
Emails:
- Business:
- peloquin@cop.ufl.edu